You have 4 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematopoietic cell transplant

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)

Recruiting
  • Viral Associated Malignancies
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 20, 2022

Acute Myocardial Infarction Trial (Placebo, Mesenchymal Precursor Cells (MPC) 12.5 M, Mesenchymal Precursor Cells (MPC) 25 M)

Completed
Has Results
  • Acute Myocardial Infarction
  • Placebo
  • +2 more
  • (no location specified)
Jun 3, 2022

Oral Mucositis (Ulcerative), Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic

Recruiting
  • Oral Mucositis (Ulcerative)
  • +3 more
  • Photobiomodulation
  • Routine Oral Care and Analgesia
  • Birmingham, Alabama
  • +6 more
Jan 18, 2022

Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Seoul, Korea, Republic of
    Severance Hospital
Aug 29, 2021

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, TGCT Trial in Germany, Poland, Ukraine (AMB-05X)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • +3 more
  • AMB-05X
  • Berlin, Germany
  • +4 more
Oct 5, 2022

B-cell Non-Hodgkin's Lymphoma Trial (Fully Human Anti-CD19/CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell

Not yet recruiting
  • B-cell Non-Hodgkin's Lymphoma
  • Fully Human Anti-CD19/CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection
  • (no location specified)
Oct 12, 2021

Multiple Myeloma Trial in Roma, Rome (ATAC-seq and ChIP-seq)

Recruiting
  • Multiple Myeloma
  • ATAC-seq and ChIP-seq
  • Roma, Italy
  • +1 more
May 4, 2023

Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)

Completed
Has Results
  • Nasopharyngeal Carcinoma
  • Marietta, Georgia
  • +17 more
Jan 17, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)

Not yet recruiting
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Drug: Pembrolizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 7, 2022

HIV Trial in Houston (Aldesleukin)

Completed
  • HIV Infections
  • Houston, Texas
    Thomas Street Clinic C605-020 CRS
Oct 27, 2021

HIV Trial in Bangkok (Aldesleukin, ART)

Completed
  • HIV Infections
  • Bangkok, Ratchathewi, Thailand
  • +1 more
Oct 27, 2021

Down Syndrome, Polyendocrinopathies, Autoimmune, Respiratory Tract Infections Trial in Denver (Phlebotomy)

Completed
  • Down Syndrome
  • +3 more
  • Phlebotomy
  • Denver, Colorado
    University of Colorado, Denver
Apr 15, 2022

Lymphoma, B-Cell Trial in Beijing, Shanghai, Chengdu (Keynatinib)

Recruiting
  • Lymphoma, B-Cell
  • Beijing, Beijing, China
  • +3 more
Apr 17, 2022

Peripheral T-cell Lymphoma Trial in Worldwide (Belinostat)

Completed
Has Results
  • Peripheral T-cell Lymphoma
  • Duarte, California
  • +116 more
Oct 14, 2021

Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma Trial in Shanghai (SHR1459 ;YY-20394, Gemcitabine-Oxaliplatin)

Recruiting
  • Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital Affiliated to The Shanghai Jiao Tong University
Sep 22, 2021

Refractory Diffuse Large B Cell Lymphoma Trial in United States (KTE-C19, Atezolizumab, Cyclophosphamide)

Active, not recruiting
Has Results
  • Refractory Diffuse Large B Cell Lymphoma
  • KTE-C19
  • +3 more
  • Duarte, California
  • +4 more
Apr 27, 2022

NSCLC Trial in Canton, Houston (FWD1509 MsOH)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • FWD1509 MsOH
  • Canton, Ohio
  • +1 more
Jul 20, 2022

Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL Trial in Japan (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Part1: Advanced B-cell Malignancies
  • +2 more
  • Chiba-shi, Japan
  • +13 more
Jan 31, 2022

Omitting Clinical Target Volume of Unresectable Stage III

Completed
  • Stage III Non-small-cell Lung Cancer
  • The enrollment was randomly (1:1) assigned into the study group with CTV-omitted IMRT under PET-CT guidance and the control group with CTV-delineated IMRT using a random number table.
  • (no location specified)
Aug 29, 2022

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Sintilimab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 1, 2021

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Odronextamab multiple dose levels)

Recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Odronextamab multiple dose levels
  • Orange, California
  • +20 more
Dec 14, 2022

Pediatric Pertussis in Ambulatory Settings

Recruiting
  • Pertussis/Whooping Cough
  • +2 more
  • non interventional study
  • Créteil, France
    ACTIV
Dec 22, 2022